Botulinum toxin in the lower orbicularis oculi: what to assess

The lower periorbital area often seems the ideal place for refinement: small lines, a slight crinkled look when smiling, a discreet bag "puffed up" by the muscle. But the lower orbicularis is, at the same time, a structure that supports the eyelid. Weakening it without assessing tone can turn a small concern into a hard-to-solve complication.

This page is an assessment guide. It does not teach injection points or doses. The focus is on how to decide whether toxin is worth considering in this area and when it is better to decline, at the discretion of the qualified professional and following the rules of their professional council in Brazil.

What does the lower orbicularis do?

The orbicularis oculi muscle is a sphincter that closes the eyelids and takes part in blinking, squinting and smiling. Its pretarsal portion, in the lower eyelid, adheres to the tarsus and helps keep the eyelid margin resting against the eyeball. The orbital portion, more peripheral, pulls the skin and the lateral and medial tissue during smiling and forced contraction.

When the patient smiles, the muscle contracts and pushes the skin upward, marking lateral lines and creating a "wheel" under the eye. In some people, the muscle is hypertrophic and forms a "roll" under the lashes, which can be mistaken for an eye bag. That roll is the most common reason for the question about toxin, and precisely the one that demands the most care.

In addition, the orbicularis takes part in pumping tears, contributing to drainage through the lacrimal system. Reducing the strength of the muscle can alter drainage and lead to tearing or dry eye, depending on the case.

Why does a lax eyelid change everything?

A young, firm eyelid has a margin resting on the globe, supported by the lateral and medial canthal tendons, the tarsus and muscle tone. With aging, the canthal tendon lengthens, the tarsus loosens and the muscle works harder to compensate. If that muscle is weakened, the whole structure may give way.

The possible result is ectropion (margin turning outward), retraction (margin dropping and showing sclera) and ocular exposure. It does not always happen right away; sometimes the patient notices it after a few days, when the toxin reaches its full effect. To understand the components, see the page on ectropion and eyelid retraction after a procedure.

Which tests help assess eyelid tone?

Two simple bedside tests guide the decision. They do not replace the assessment of an ophthalmologist or an oculoplastic surgeon when there is doubt, but they help with screening.

• Snap-back test: gently pull the lower eyelid down, away from the eyeball, and release without blinking. In a firm eyelid, it returns quickly. If it is slow to return or only returns with a blink, tone is reduced.
• Distraction test: carefully pull the eyelid away from the eyeball in the anterior direction. A very large distance between the eyelid and the eye suggests laxity.

Also record the position of the margin relative to the limbus and sclera, the look of the lateral corner and the degree of eye bag. Photos at rest, from the front and with the gaze slightly upward help with comparison later.

Which factors raise the risk?

Some findings tip the decision toward abstaining:

• An eyelid that fails the snap-back and distraction tests.
• Baseline scleral show, especially if there is asymmetry.
• Prior lower eyelid surgery (blepharoplasty), which alters support, and scars in the area.
• Conditions that affect the eye or eyelid, such as dry eye syndrome, thyroid disease with exophthalmos and facial paralysis.
• Frequent contact lens use or complaints of eye irritation.
• Prominent fat pads, where loss of tone accentuates the bulge.
• Advanced age, with skin laxity and generalized tendon laxity.

Young patients, with firm skin and a well-supported margin, have a different risk profile, but not zero. The consent should mention ectropion and dry eye anyway.

What can the toxin solve, and what does it not solve?

Toxin in the orbicularis can, in selected cases, soften fine lines that form on contraction and reduce the prominence of the pretarsal "roll." Other concerns, on the other hand, usually have a different origin:

Those who seek a "more open eye" or a "younger look" need an honest conversation: treatment of the lower orbicularis is limited and, if poorly indicated, can open or close the eye in an unwanted way. See also dark circles: types and assessment, periorbital anatomy for injectables and toxin for crow's feet, to put the decision in context.

What if the patient already has swelling or eye bags?

Swelling and eye bags call for extra attention. Toxin in the orbicularis can reduce local lymphatic pumping and worsen puffiness, especially in those who already have a tendency. If the concern is an eye bag, the reasoning shifts to other options, and referral to an eyelid specialist is reasonable. The pages malar bags: assessment and chronic eyelid swelling after filler help tell the causes apart.

How to manage a complication

If, after the procedure, the patient notices dry eye, tearing, discomfort or a change in eyelid position, the follow-up should be quick. Document the picture with a photo, assess the cornea (or refer, if you lack the resources), advise lubrication as prescribed and follow until resolution. In significant ectropion, the support of an ophthalmologist is essential. The page dry eye and lagophthalmos after toxin details the condition.

How to document the decision

In an area where abstaining is often the best answer, recording the decision is a safety tool. Note the tests done, the result, the reason for the approach and the alternatives offered. If the patient insists and you disagree with the indication, a well-grounded refusal is part of responsible professional practice. For the full set of toxin risks, see complications with botulinum toxin and botulinum toxin: fundamentals.